Celiac disease patients have no FDA-approved treatment to prevent intestinal damage from accidental gluten exposure

Celiac disease patients currently lack any FDA-approved medication to prevent the intestinal damage that occurs when they consume gluten, forcing them to rely solely on strict dietary avoidance. This creates constant anxiety about cross-contamination, accidental exposure, and uncontrollable immune responses. Patients desperately need a pharmaceutical solution that can mitigate damage when gluten exposure inevitably happens.